Received Sep 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | — |
No adverse event; HCP called to report that a patient missed/delayed her second dose of GARDASIL 9. HCP was made aware of the missed/delayed dose today, 08/26/2025, when the patient arrived at the pharmacy to receive her second dose. The patient was 12 years old when; This spontaneous report was received from a pharmacist and refers to a 23-year-old female patient. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medication. On an unspecified date in 2014, when the patient was 12 years old was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), at a dose of 0.5 mL for prophylaxis (route of administration, anatomical location, lot number and expiration date were not reported). On 26-AGO-2025, the health care progressional was aware of the missed/delayed dose, when the patient arrived at the pharmacy to receive her second dose, the patient was 23-year-old now. No symptoms reported. Lot # is being requested and will be submitted if received.